◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
博瑞医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021
+Revenue 1.2B 1.3B 1.2B 1.0B 1.1B
Revenue Growth % -4.6% 8.7% 16.0% -3.3% --
Total Revenue 1.2B 1.3B 1.2B 1.0B 1.1B
Cost Of Revenue 602.0M 545.0M 521.0M 376.0M 461.0M
+Gross Profit 622.0M 738.0M 659.0M 641.0M 591.0M
Gross Margin % 50.8% 57.5% 55.8% 63.0% 56.2%
Total Operating Cost 1.2B 1.1B 1.0B 797.0M 809.0M
Selling Expenses 78.0M 71.7M 64.1M 70.1M 42.8M
Admin Expenses 155.0M 139.0M 116.0M 115.0M 103.0M
Rd Expenses 305.0M 297.0M 249.0M 207.0M 173.0M
Finance Expenses 52.2M 40.9M 24.1M 9.8M 5.7M
+Operating Income 14.7M 160.0M 190.0M 242.0M 259.0M
Operating Margin % 1.2% 12.5% 16.1% 23.8% 24.6%
Non Operating Income 207,500 48,300 199,000 1.1M 106,900
Non Operating Expenses 962,800 3.1M 1.7M 999,000 1.6M
Investment Income -19.3M -11.6M -14.7M 4.0M 9.2M
Fair Value Change Income 13.8M -5.7M -520,000 -3.4M 789,700
Asset Disposal Income -- -- -- 9,900 6,300
Asset Impairment Loss 17.5M 19.9M 21.5M 14.6M 9.4M
Other Income 38.7M 30.0M 30.3M 20.9M 5.7M
Income Before Tax 13.9M 157.0M 189.0M 242.0M 257.0M
Income Tax -23.0M 15.9M 15.3M 30.8M 19.9M
+Net Income 37.0M 141.0M 173.0M 211.0M 238.0M
Net Margin % 3.0% 11.0% 14.7% 20.7% 22.6%
Net Income Attributable 54.5M 189.0M 202.0M 240.0M 244.0M
Minority Interest -17.6M -47.9M -29.0M -28.2M -6.4M
Eps Basic 0.13 0.45 0.48 0.58 0.60
Eps Diluted 0.13 0.45 0.48 0.58 0.60
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021
Cash And Equivalents 961.0M 765.0M 998.0M 1.2B 337.0M
Trading Financial Assets -- -- 50.6M 50.1M 763,400
Accounts Receivable 316.0M 328.0M 283.0M 303.0M 373.0M
Notes Receivable 200,000 1.4M 2.4M 778,500 500,000
Notes And Accounts Receivable 317.0M 329.0M 285.0M 304.0M 374.0M
Prepayments 62.2M 105.0M 52.4M 44.4M 35.8M
Inventory 364.0M 365.0M 345.0M 280.0M 200.0M
Total Current Assets 1.8B 1.6B 1.8B 1.9B 993.0M
Long Term Equity Investment 123.0M 39.0M 43.5M 35.4M 52.3M
Fixed Assets 1.5B 1.5B 718.0M 402.0M 238.0M
Fixed Assets Total 1.5B 1.5B 718.0M 402.0M 238.0M
Construction In Progress 1.2B 1.2B 1.7B 1.7B 1.1B
Construction In Progress Total 1.2B 1.2B 1.7B 1.7B 1.1B
Intangible Assets 79.5M 89.5M 93.7M 81.6M 80.8M
Long Term Deferred Expenses 36.4M 43.1M 30.2M 26.9M 25.8M
Total Non Current Assets 4.0B 3.5B 3.2B 2.7B 2.0B
Total Assets 5.8B 5.2B 5.0B 4.7B 3.0B
Short Term Borrowings 110.0M 115.0M 157.0M 124.0M 257.0M
Accounts Payable 166.0M 211.0M 188.0M 217.0M 208.0M
Advance Receipts -- -- -- -- --
Contract Liabilities 25.6M 28.0M 24.0M 29.5M 20.3M
Total Current Liabilities 1.3B 1.1B 922.0M 812.0M 583.0M
Long Term Borrowings 730.0M 1.1B 1.2B 1.2B 619.0M
Total Non Current Liabilities 1.7B 1.7B 1.7B 1.6B 645.0M
Total Liabilities 3.0B 2.7B 2.6B 2.4B 1.2B
Paid In Capital 423.0M 422.0M 422.0M 422.0M 410.0M
Capital Reserve 1.1B 982.0M 1.1B 1.0B 739.0M
Surplus Reserve 98.6M 85.5M 67.2M 58.5M 44.1M
Retained Earnings 968.0M 961.0M 830.0M 685.0M 511.0M
Minority Equity 325.0M 42.7M 49.0M 50.0M 63.4M
Equity Attributable 2.5B 2.4B 2.4B 2.2B 1.7B
Total Equity 2.8B 2.4B 2.4B 2.2B 1.7B
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021
Cash From Sales 1.2B 1.0B 976.0M 1.1B 872.0M
Tax Refunds Received 44.4M 56.5M 44.7M 78.5M 46.3M
Total Operating Cash Inflow 1.3B 1.1B 1.1B 1.2B 926.0M
Cash Paid For Goods 269.0M 204.0M 319.0M 341.0M 356.0M
Cash Paid To Employees 284.0M 266.0M 241.0M 210.0M 169.0M
Taxes Paid 63.2M 82.0M 74.1M 61.4M 39.2M
Total Operating Cash Outflow 929.0M 872.0M 881.0M 870.0M 749.0M
Operating Cash Flow 325.0M 246.0M 195.0M 311.0M 176.0M
Total Investing Cash Inflow 90.8M 156.0M 134.0M 612.0M 332.0M
Total Investing Cash Outflow 713.0M 596.0M 574.0M 1.5B 1.2B
Investing Cash Flow -623.0M -440.0M -440.0M -872.0M -890.0M
Cash From Borrowings 895.0M 802.0M 678.0M 1.6B 882.0M
Dividends And Interest Paid 118.0M 136.0M 115.0M 100.0M 54.3M
Debt Repayments 850.0M 787.0M 560.0M 474.0M 211.0M
Total Financing Cash Inflow 1.5B 926.0M 746.0M 1.9B 969.0M
Total Financing Cash Outflow 1.0B 951.0M 685.0M 574.0M 265.0M
Financing Cash Flow 498.0M -24.5M 61.6M 1.4B 704.0M
Net Change In Cash 201.0M -217.0M -181.0M 819.0M -6.3M
Ending Cash Balance 955.0M 754.0M 971.0M 1.2B 333.0M
Capex 453.0M 257.0M 404.0M 727.0M 910.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...